Stocks TelegraphStocks Telegraph
Stock Ideas

BBLG Financial Statements and Analysis

NASDAQ : BBLG

Bone Biologics Corporation

$1.17
-0.0192-1.61%
Open: 9:41 AM
59.02
BESG ScoreESG Rating

BBLG FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

BBLG Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue00000
cost of revenue00000
gross profit00000
gross profit ratio00000
research and development expenses429.747K350.442K245.625K447.077K1.575M
general and administrative expenses521.274K459.223K657.911K712.931K506.04K
selling and marketing expenses00000
selling general and administrative expenses521.274K459.223K657.911K712.931K506.04K
other expenses00000
operating expenses951.021K809.665K903.536K1.16M2.081M
cost and expenses951.021K809.665K903.536K1.16M2.081M
interest income19.993K15.147K255.00349.00536.00
interest expense00000
depreciation and amortization05.00903.536K390.226K2.081K
ebitda-951.021K-809.66K0-769.782K-2.081M
ebitda ratio00000
operating income-951.021K-809.665K-903.54K-1.16M-2.081M
operating income ratio00000
total other income expenses net10.019K25.932K37.566K-390.226K161.181K
income before tax-941.002K-783.733K-865.97K-1.55M-1.92M
income before tax ratio00000
income tax expense00-903.536K-349.00-2.081K
net income-941.002K-783.733K-865.97K-1.55M-1.92M
net income ratio00000
eps-2.37-0.67-1.31-2.90-4.90
eps diluted-2.37-0.67-1.31-2.90-4.90
weighted average shs out1.753M1.168M660.00K534.238K391.798K
weighted average shs out dil1.753M1.168M660.928K534.238K391.798K
Graph

BBLG Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents3.566M2.332M3.228M3.027M4.453M
short term investments00000
cash and short term investments3.566M2.332M3.228M3.027M4.453M
net receivables000328.844K0
inventory00-328.844K-328.844K0
other current assets499.392K861.396K611.94K711.194K523.758K
total current assets4.066M3.193M3.84M3.738M4.976M
property plant equipment net00000
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets00000
total non current assets00000
other assets0000523.758K
total assets4.066M3.193M3.84M3.738M4.976M
account payables190.057K231.872K146.186K360.662K1.103M
short term debt00000
tax payables00000
deferred revenue044.98K000
other current liabilities83.345K7.655K18.44K470.74K80.514K
total current liabilities273.402K284.507K164.626K831.402K1.183M
long term debt00000
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities00000
total non current liabilities00000
other liabilities00000
capital lease obligations00000
total liabilities273.402K284.507K164.626K831.402K1.183M
preferred stock00000
common stock2.096K1.315K1.016K534.003.135K
retained earnings-83.50M-82.559M-81.775M-80.909M-79.359M
accumulated other comprehensive income loss00000
other total stockholders equity87.29M85.466M85.449M83.815M83.149M
total stockholders equity3.792M2.909M3.675M2.906M3.793M
total equity3.792M2.909M3.675M2.906M3.793M
total liabilities and stockholders equity4.066M3.193M3.84M3.738M4.976M
minority interest00000
total investments00000
total debt00000
net debt-3.566M-2.332M-3.228M-3.027M-4.453M
Graph

BBLG Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00000
stock based compensation17.443K52.681K71.139K20.026K16.67K
change in working capital-118.79K-452.811K-514.506K-494.894K-609.903K
accounts receivables00000
inventory00000
accounts payables85.686K-137.076K41.616K-586.374K-590.099K
other working capital-204.476K-315.735K-556.122K91.48K-19.804K
other non cash items-79.028K152.446K-24.763K-160.646K-1.27M
net cash provided by operating activities-895.865K-1.303M-2.018M-2.555M-3.633M
investments in property plant and equipment00000
acquisitions net00000
purchases of investments00000
sales maturities of investments00000
other investing activites00000
net cash used for investing activites00000
debt repayment00000
common stock issued299.001.504M591.998K04.452M
common stock repurchased00000
dividends paid00000
other financing activites299.001.504M004.452K
net cash used provided by financing activities299.001.504M591.998K04.452M
effect of forex changes on cash00000
net change in cash-895.566K201.065K-1.426M-2.555M819.49K
cash at end of period2.332M3.228M3.027M4.453M7.008M
cash at beginning of period3.228M3.027M4.453M7.008M6.188M
operating cashflow-895.865K-1.303M-2.018M-2.555M-3.633M
capital expenditure00000
free cash flow-895.865K-1.303M-2.018M-2.555M-3.633M
Graph

Frequently Asked Questions

How did Bone Biologics Corporation do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, BBLG generated $0.00 in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did Bone Biologics Corporation report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Bone Biologics Corporation reported a $0.00 Gross Profit for the quarter ended Jun 30, 2024.

Have BBLG's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. BBLG incurred $951.02K worth of Operating Expenses, while it generated -$951.02K worth of Operating Income.

How much Net Income has BBLG posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Bone Biologics Corporation, the company generated -$941.00K in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Bone Biologics Corporation have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Bone Biologics Corporation as of the end of the last quarter was $3.57M.

What are BBLG's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, BBLG had Total Net Receivables of $0.00.

In terms of Total Assets and Current Assets, where did Bone Biologics Corporation stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of BBLG were $4.07M, while the Total Assets stand at $4.07M.

As of the last quarter, how much Total Debt did Bone Biologics Corporation have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of BBLG's debt was $0.00 at the end of the last quarter.

What were BBLG's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, BBLG reported total liabilities of $273.40K.

How much did BBLG's Working Capital change over the last quarter?

Working Capital Change for BBLG was -$118.79K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

BBLG generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. BBLG generated -$895.87K of Cash from Operating Activities during its recently reported quarter.

What was BBLG's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. BBLG reported a -$895.57K Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph